Related Experiment Video
Updated: Aug 7, 2026
09:33
Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Base sequence specificity of three 2-chloroethylnitrosoureas
W T Briscoe1, S P Anderson, H E May
1Department of Biochemistry, School of Medicine, Oral Roberts University, Tulsa, OK 74171.
Biochemical Pharmacology
|September 15, 1990
Summary
Chemical modifications to guanine, a DNA base, are common with carcinogens and anti-cancer drugs. Guanine runs are more susceptible to alkylation by specific nitrosoureas, influencing drug efficacy.
Area of Science:
- Chemical Biology
- Genomics
- Drug Discovery
Background:
- Chemical modifications of guanine bases in DNA are frequent outcomes of exposure to carcinogens and anti-cancer agents.
- Understanding these modifications is crucial for drug development and cancer research.
Purpose of the Study:
- To determine the base sequence specificity of guanine alkylation by three 2-chloroethylnitrosoureas.
- To investigate how DNA sequence context influences the susceptibility of guanine to chemical modification.
Main Methods:
- Analysis of guanine alkylation patterns using specific 2-chloroethylnitrosoureas (BCNU, CCNU, methyl-CCNU).
- Quantification of alkylation at different guanine positions (N-7, O-6) based on neighboring bases.
Main Results:
- Guanines within guanine-rich sequences (runs of guanines) are significantly more susceptible to alkylation than those in random sequences.
- The degree of increased susceptibility varies with the alkylation site (N-7 vs. O-6) and the specific alkyl group.
- Guanines flanked by thymines on both sides show reduced susceptibility to specific modifications.
Conclusions:
- Base sequence context profoundly impacts the site and extent of guanine alkylation by nitrosoureas.
- This sequence-dependent modification is vital for understanding the anti-tumor activity of drugs and the role of DNA lesions in gene regulation.
Related Concept Videos
02:53Conservative Site-specific Recombination and Phase Variation
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
02:36Transfer RNA Synthesis
One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
01:11Restriction Enzymes
Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...